CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

10.1007/s10549-018-5027-0

Saved in:
Bibliographic Details
Main Authors: Drogemoller, Britt I, Wright, Galen EB, Shih, Joanne, Monzon, Jose G, Gelmon, Karen A, Ross, Colin JD, Amstutz, Ursula, Carleton, Bruce C, Chang, Wan C, Connolly, Mary B, Dionne, Francois, Groeneweg, Gabriella, Loucks, Catrina M, MacLeod, Stuart M, Pritchard, Sheila, Rassekh, Shahrad R, Sanatani, Shubhayan, Bhavsar, Amit P, Rieder, Michael J, Shear, Neil H, Ito, Shinya, Liu, Geoffrey, Khayat, Philip, Bernstein, Daniel, Lesko, Lawrence J, Aminkeng, Folefac
Other Authors: MEDICINE
Format: Review
Language:English
Published: SPRINGER 2022
Subjects:
Science & Technology
Life Sciences & Biomedicine
Oncology
Clinical practice guidelines
CYP2D6
Pharmacogenomics
Systematic review
Tamoxifen
TAMOXIFEN DOSE-ESCALATION
BONE-MINERAL DENSITY
ESTROGEN-RECEPTOR
POSTMENOPAUSAL WOMEN
AROMATASE INHIBITORS
ENDOXIFEN CONCENTRATIONS
LEVEL METAANALYSIS
ACTIVE METABOLITE
GENOTYPE
THERAPY
Online Access:https://scholarbank.nus.edu.sg/handle/10635/235040
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://scholarbank.nus.edu.sg/handle/10635/235040

Similar Items